Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 1,350.62 Million |
| USD 2,128.15 Million | |
| % | |
North America Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems And Others), Surgical Procedure (Thoracotomy And Minimally Invasive Surgery), Patient Type (Male And Female), End User (Hospitals, Ambulatory Surgical Centres, Academic & Research Laboratories, Speciality Cancer Care Centres And Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others) - Industry Trends and Forecast to 2029.
A wedge surgery is a procedure used to remove lung cancer along with a little amount of good tissue. Segmental resection refers to the removal of a bigger portion of the lung. A lobectomy is a procedure to remove one of the five lobes of the lung. Pneumonectomy is the surgical removal of the whole lung.
North America lung cancer surgery market is expected to gain significant market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.6% in the forecast period of 2022 to 2029 and is expected to reach USD 2,128.15 million by 2029 from USD 1,350.62 million in 2021.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable 2019-2014)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
By Product Type (Surgical Instruments, Monitoring & Visualizing System, Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems And Others), Surgical Procedure (Thoracotomy And Minimally Invasive Surgery), Patient Type (Male And Female), End User (Hospitals, Ambulatory Surgical Centres, Academic & Research Laboratories, Speciality Cancer Care Centres And Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico
|
|
Market Players Covered
|
The major companies which are dealing in the market are AngioDynamics, Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc, Olympus Corporation among others.
|
Market Definition
Depending on the kind, location, and stage of their lung cancer as well as any other medical issues, certain people may be candidates for lung cancer surgery. This kind of surgery is used to treat lung cancer. It involves removing the tumour, some lung tissue around it, and frequently some lymph nodes as well. When lung cancer is limited and not anticipated to have spread, surgery to remove the tumour is thought to be the best option. This includes carcinoid tumours and non-small cell lung cancer in its early stages.
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
Lung cancer is the most common leading cause of death in men and women globally. The incidence and mortality from lung cancer increasing globally due to the commencement of the tobacco epidemic in various countries and populations in the developing world. Lung cancer, including trachea and bronchus cancer, is widely regarded as a threat to global health, causing a heavy burden on individuals and families. Lung cancer is a malignant tumor characterized by the uncontrolled growth of cell tissues in the lung. It is the second most commonly diagnosed and has the highest mortality rate of all cancers in both men and women. According to the GLOBOCAN, Lung cancer is the most common malignancy diagnosed worldwide, with an age-standardized incidence rate of 22.5 per 100,000 person-years. Men have a higher chance of developing lung cancer than women. However, since the middle of the 1990s, male patient incidence rates have decreased in most developed countries, while female patient incidence rates have steadily grown.
Technology advancement are of immense importance in the surgery of lung cancer. The importance of technological advancement has now taken almost every aspect of our lives. However, the most significant benefits are due to technological advances in health care. By developing new methodologies for treatment, the health system's technology becomes more effective. Recent technological advances have saved millions of lives and increased the quality of life.
In the people of all ages lung cancer is a well-known and prevalent disorder. The cutting –edge technology helps in providing better options for screening the disease. Thus, introduction of technological advanced products for the treatment of lung cancer acts as a driver for the growth of the market
The growing awareness programs of lung cancer by non-profit, private and public organization is leveraging to boost the market growth. These initiatives aim to reducing stigma and prejudice, prevent diseases and promoting research.
The above statement show that awareness among the population regarding lung cancer has increased as there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed at early stages. Thus, raising awareness among populations is acting as a driver for the lung cancer surgery market.
Opportunities
Rise of Minimally Invasive Techniques in Lung Cancer Surgery
Surgery is the standard of therapy for early-stage non-small cell lung cancer (NSCLC). Minimally invasive surgery (MIS), is now preferred to conventional open surgery. It has been shown that MIS procedures like video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery (RATS) lessen postoperative problems and decrease hospital stays. Therefore, there are launches of new minimally invasive techniques.
Growing demand for minimally invasive technique is also beneficial for further economic growth and healthcare sector growth and it is primarily fruitful as it significantly affects the development of better and advanced medical technique in the market. Thereby surge in minimally techniques in lung cancer surgery is a greater opportunity for the lung cancer surgery market.
Restraints/Challenges
However, the barriers to the lung cancer surgery techniques and high cost of lung cancer surgery process in some of the regions may impede the less growth of the lung cancer surgery hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be the challenging factors for the growth of the market
This lung cancer surgery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer surgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
All industries, including healthcare, medical device services, automotive, pharmaceutical, and many more have been severely disrupted by the new coronavirus. The epidemic has caused supply chain disruptions and shutdowns of large-scale manufacturing, which have had an effect on the economics of almost every country in the world. The non-small cell lung cancer diagnostic sector was also impacted by the pandemic. Patients choose to stay at home rather than receive diagnosis and treatment out of fear of contracting the virus. Worldwide, during the COVID-19 pandemic, many people had COVID-19 and post-COVID-19 sequelae such cardiovascular disease, diabetes, and kidney issues. The healthcare system changed its emphasis on containing COVID-19 as cases increased, delaying the diagnosis and treatment of other chronic illnesses like cancer in the process. As a result, the pandemic scenario is predicted to have a negative effect on the lung cancer diagnostics industry. As a result, COVID-19 patients occupied all available beds in hospitals and clinics, whereas lung cancer patients received less attention. Additionally, the market growth has been affected by clinic accessibility issues, social exclusion, and population lockdown, all of which slow down referrals and patient flow.
The market for lung cancer surgery, however, may see growth due to a slight easing in COVID-19 cases, which will result in increased demand for lung cancer diagnosis and surgery with patients coming forward to clinics and hospitals for treatment. Cases of COVID-19 are declining in number, and vaccination against it is increasing across the North-America region.
Recent Development
North America lung cancer surgery market is segmented into product type, surgical procedure, patient type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
On the basis of product type, the North America lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing system, endosurgical equipment, robotic-assisted thoracic surgery systems and others.
Surgical Procedure
On the basis of surgical procedure, the North America lung cancer surgery market is segmented into thoracotomy and minimally invasive surgery.
Patient Type
On the basis of patient type, the North America lung cancer surgery market is segmented into male and female.
End User
On the basis of end user, the North America lung cancer surgery market is segmented into hospitals, ambulatory & surgical centres, academic & research institutes, speciality cancer care centers and others.
Distribution Channel
On the basis of distribution channel, the North America lung cancer surgery market is segmented into direct tender, retail sales, online sales and others.
The lung cancer surgery market is analyzed and market size insights and trends are provided by country, product type, surgical procedure, patient type, end user and distribution channel as referenced above.
The U.S. dominates the North America lung cancer surgery market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rising need of the verification and validation of oncological surgical processes in the country and rapid research development.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
The lung cancer surgery market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on lung cancer surgery market.
Some of the major players operating in the lung cancer surgery market are AngioDynamics, Ackermann, Scanlan International, KLS Martin Group, Wexler Surgical, Lepu Medical Technology (Beijing) Co., Ltd., Intuitive Surgical, FusionKraft, Surgical Holdings, GerMedUSA, Medtronic, Accuray Incorporated, Teleflex Incorporated, KARL STORZ SE & Co. KG, TROKAMED GmbH, Richard Wolf GmbH, Sontec Instruments, Inc., asap endoscopic products GmbH, FUJIFILM Holdings America Corporation, Ambu A/S., Johnson & Johnson Services, Inc., Olympus Corporation and among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, North America vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA LUNG CANCER SURGERY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 EPIDEMIOLOGY
5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY
5.2 TREATMENT RATE BY GENDER
5.3 MORTALITY BY GENDER
6 REGULATIONS OF THE NORTH AMERICA LUNG CANCER SURGERY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES
7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS
7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING
7.2 RESTRAINTS
7.2.1 HIGH COST OF LUNG CANCER SURGERY
7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS
7.2.3 STRINGENT REGULATORY FRAMEWORKS
7.3 OPPORTUNITIES
7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY
7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY
7.4 CHALLENGES
7.4.1 DEARTH OF SKILLED ONCOLOGISTS
7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES
8 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SURGICAL INSTRUMENTS
8.2.1 HAND INSTRUMENTS
8.2.1.1 STAPLER
8.2.1.2 FORCEPS
8.2.1.3 ELECTRIC HOOK
8.2.1.4 RETRACTORS
8.2.1.5 CLAMPS
8.2.1.6 SCISSORS
8.2.1.7 ELEVATORS
8.2.1.8 HEMOCLIP APPLIERS
8.2.1.9 ULTRASOUND SCALPEL
8.2.1.10 RIB SHEARS
8.2.1.11 CUTTERS
8.2.1.12 NEEDLE HOLDER
8.2.1.13 TROCAR
8.2.1.14 OTHERS
8.2.2 POWERED SURGICAL EQUIPMENT
8.2.2.1 ADVANCED ENERGY INSTRUMENTS
8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS
8.2.2.1.2 OTHERS
8.2.2.2 BASIC ENERGY INSTRUMENTS
8.2.2.2.1 BIPOLAR INSTRUMENTS
8.2.2.2.2 MONOPOLAR INSTRUMENTS
8.3 MONITORING & VISUALISING SYSTEM
8.3.1 CAMERAS & VIDEO SUPPORT
8.3.2 BRONCHOSCOPES
8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
8.3.4 THORACOSCOPES
8.3.5 MEDIASTINOSCOPES
8.3.6 OTHERS
8.4 ENDOSURGICAL EQUIPMENTS
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS
8.6 OTHERS
9 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
9.1 OVERVIEW
9.2 THORACOTOMY
9.2.1 LOBECTOMY
9.2.1.1 SURGICAL INSTRUMENTS
9.2.1.2 MONITORING & VISUALISING SYSTEMS
9.2.1.3 ENDOSURGICAL EQUIPMENT
9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.1.5 OTHERS
9.2.2 SLEEVE RESECTION
9.2.2.1 SURGICAL INSTRUMENTS
9.2.2.2 MONITORING & VISUALISING SYSTEMS
9.2.2.3 ENDOSURGICAL EQUIPMENT
9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.2.5 OTHERS
9.2.3 SEGMENTECTOMY
9.2.3.1 SURGICAL INSTRUMENTS
9.2.3.2 MONITORING & VISUALISING SYSTEMS
9.2.3.3 ENDOSURGICAL EQUIPMENT
9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.3.5 OTHERS
9.2.4 PNEUMONECTOMY
9.2.4.1 SURGICAL INSTRUMENTS
9.2.4.2 MONITORING & VISUALISING SYSTEMS
9.2.4.3 ENDOSURGICAL EQUIPMENT
9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.4.5 OTHERS
9.2.5 OTHERS
9.3 MINIMALLY INVASIVE SURGERIES
9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)
9.3.1.1 SURGICAL INSTRUMENTS
9.3.1.2 MONITORING & VISUALISING SYSTEMS
9.3.1.3 ENDOSURGICAL EQUIPMENT
9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.1.5 OTHERS
9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)
9.3.2.1 SURGICAL INSTRUMENTS
9.3.2.2 MONITORING & VISUALISING SYSTEMS
9.3.2.3 ENDOSURGICAL EQUIPMENT
9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.2.5 OTHERS
10 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 MALE
10.2.1 GERIATRIC
10.2.1.1 THORACOTOMY
10.2.1.2 MINIMALLY INVASIVE SURGERIES
10.2.2 ADULTS
10.2.2.1 THORACOTOMY
10.2.2.2 MINIMALLY INVASIVE SURGERIES
10.2.3 PEDIATRIC
10.2.3.1 THORACOTOMY
10.2.3.2 MINIMALLY INVASIVE SURGERIES
10.3 FEMALE
10.3.1 GERIATRIC
10.3.1.1 THORACOTOMY
10.3.1.2 MINIMALLY INVASIVE SURGERIES
10.3.2 ADULTS
10.3.2.1 THORACOTOMY
10.3.2.2 MINIMALLY INVASIVE SURGERIES
10.3.3 PEDIATRIC
10.3.3.1 THORACOTOMY
10.3.3.2 MINIMALLY INVASIVE SURGERIES
11 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC HOSPITALS
12.2.2 PRIVATE HOSPITALS
12.3 AMBULATORY SURGICAL CENTERS
12.4 SPECIALTY CANCER CARE CENTERS
12.5 ACADEMIC AND RESEARCH LABORATORIES
12.6 OTHERS
13 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 JOHNSON & JOHNSON SERVICES, INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ACCURAY INCORPORATED
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 INTUITIVE SURGICAL
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FUJIFILM HOLDINGS CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AMBU A/S.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ANGIODYNAMICS
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ACKERMANN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCTPORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 FUSIONKRAFT
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 GERMED USA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 KLS MARTIN GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 KARL STORZ SE & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEDTRONICS (2021)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 OLYMPUS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCTPORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 RICHARD WOLF GMBH.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 SURGICAL HOLDINGS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SONTEC INSTRUMENTS, INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SCANLAN INTERNATIONAL
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TELEFLEX INCORPORATED
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCTPORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TROKAMED GMBH.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 WEXLER SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020
TABLE 2 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 7 NORTH AMERICA POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 11 NORTH AMERICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 14 NORTH AMERICA ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 50 NORTH AMERICA OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
FIGURE 1 NORTH AMERICA LUNG CANCER SURGERYMARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 NORTH AMERICA LUNG CANCER SURGERYMARKET: DATA TRIANGULATION
FIGURE 4 NORTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT
FIGURE 5 NORTH AMERICA LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH
FIGURE 6 NORTH AMERICA LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH
FIGURE 7 NORTH AMERICA LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 NORTH AMERICA LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID
FIGURE 11 NORTH AMERICA LUNG CANCER SURGERY MARKET SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE NORTH AMERICA LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LUNG CANCER SURGERY MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA LUNG CANCER SURGERY MARKET
FIGURE 15 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021
FIGURE 20 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 23 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021
FIGURE 24 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 28 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY END USER, 2021
FIGURE 32 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 36 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 37 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 40 NORTH AMERICA LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.